Detalhe da pesquisa
1.
DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1-mediated antioxidant effects.
J Cell Mol Med
; 25(4): 2163-2175, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33345387
2.
CD25 and TGF-ß blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
J Transl Med
; 16(1): 294, 2018 10 25.
Artigo
Inglês
| MEDLINE | ID: mdl-30359281
3.
Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at single-cell level in pancreatic adenocarcinoma: a tumor marker prognostic study.
Int J Surg
; 2024 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38498399
4.
Biological and clinical implications of early-onset cancers: A unique subtype.
Crit Rev Oncol Hematol
; 190: 104120, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37660930
5.
Gene expression profiling reveals the genomic changes caused by MLN4924 and the sensitizing effects of NAPEPLD knockdown in pancreatic cancer.
Cell Cycle
; 21(2): 152-171, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34874801
6.
Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis.
Cell Cycle
; 20(4): 369-382, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33507122
7.
Aberration of ARID1A Is Associated With the Tumorigenesis and Prognosis of Sporadic Nonfunctional Pancreatic Neuroendocrine Tumors.
Pancreas
; 49(4): 514-523, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32282764
8.
PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Cell Oncol (Dordr)
; 43(1): 51-62, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31520395
9.
Author Correction: PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Cell Oncol (Dordr)
; 43(1): 63-64, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31792888
10.
TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancer.
Clin Exp Med
; 19(2): 211-218, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30673917
11.
Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway.
Cancer Lett
; 460: 42-53, 2019 09 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31233838
12.
[Prognostic analysis and clinicopathological features of 20 patients with appendiceal neuroendocrine neoplasms].
Zhonghua Wei Chang Wai Ke Za Zhi
; 21(5): 564-568, 2018 May 25.
Artigo
Chinês
| MEDLINE | ID: mdl-29774940
13.
Application of a novel embeddedness-like pancreaticojejunostomy anastomosis technique used in pancreaticoduodenectomy.
Oncol Lett
; 15(5): 8067-8071, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29849808
14.
Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer.
Cell Cycle
; 17(2): 191-199, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29157102
15.
Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.
J Cancer
; 8(16): 3362-3370, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29158809
16.
Nab-Paclitaxel Plus S-1 Shows Increased Antitumor Activity in Patient-Derived Pancreatic Cancer Xenograft Mouse Models.
Pancreas
; 45(3): 425-33, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26495780
17.
Clinical characteristics and prognostic factors of patients with gastric neuroendocrine carcinoma treated with radical surgery.
Chin Med J (Engl)
; 127(13): 2419-22, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24985576
18.
Successful treatment of a case with pancreatic neuroendocrine carcinoma with focal hepatoid differentiation: a case report and literature review.
Int J Clin Exp Med
; 7(10): 3588-94, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25419403
19.
The impact of internal stenting of pancreatojejunostomy on the pancreatic fistula rate after pancreaticoduodenectomy.
Am Surg
; 80(2): 215-6, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24480229